New Delhi, Feb 12 (IANS) Shorter, six‑month and all‑oral treatment regimens for multidrug‑resistant and rifampicin‑resistant tuberculosis (MDR/RR‑TB) are cost‑effective and deliver better health outcomes than longer regimens, an ICMR study said on Thursday.With shorter regimen, “for each additional Quality Adjusted Life Year (QALY) gained, the health system spends Rs 379 less per patient compared to the standard regimen, indicating better health outcomes at lower costs,” said the s…
Trending
- Mareechika (2026) Review: A Psychological Thriller That Weaves Mystery and Emotion Into a Compelling Cinematic Experience
- Krishna Aur Chitthi Review: Arun Govil and Darsheel Safary Deliver a Heartfelt Tale of Faith, Family, and Cricket
- Return Of The Jungle (2026) Movie Review: A Heartwarming Animated Journey Rooted in Indian Storytelling
- Shape of Momo Review: A Breathtaking Portrait of Womanhood, Patriarchy, and Belonging in the Hills of Sikkim
- Rajni Ki Baraat Review (2026): A Bold, Heartwarming Celebration of Female Courage from the Lanes of Darbhanga
- Shree Baba Neeb Karori Maharaj (2026) Movie Review: A Devotional Journey That Touches the Soul
- The Great Grand Superhero Review: Jackie Shroff’s Desi Superhero Saga Is Pure Heart and Chaos
- Ego Raman (2026) Movie Review: A Quiet Psychological Drama That Dares to Go Dark